DYNAVAX
Live / Registered — Registered (as of 14 Nov 2023)
What this means for you
Registered since 14 Nov 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97518582
- Registration number
- 7220140
- Mark type
- Word mark
- Filed
- 25 Jul 2022
- Published for opposition
- 20 Jun 2023
- Registered
- 14 Nov 2023
- Attorney of record
- Beth M. Goldman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of hepatitis, chronic viral infections, viruses and other infectious diseases, disorders, symptoms and syndromes, inflammatory diseases, disorders, symptoms and syndromes, genetic diseases, disorders, symptoms and syndromes, neurological diseases, disorders, symptoms and syndromes, allergic and autoimmune diseases, disorders, symptoms and syndromes, immune system diseases, disorders, symptoms and syndromes, cancer; vaccines; vaccine adjuvants
Owner
- Dynavax Technologies Corporation, Emeryville, CA, US
- Dynavax Technologies Corporation, Emeryville, CA, US
- Dynavax Technologies Corporation, Emeryville, CA, US
Prior registrations
Prosecution history
- 14 Nov 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Nov 2023 — REGISTERED-PRINCIPAL REGISTER
- 07 Oct 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Oct 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Aug 2023 — USE AMENDMENT FILED
- 30 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Aug 2023 — TEAS STATEMENT OF USE RECEIVED
- 15 Aug 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Jun 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jun 2023 — PUBLISHED FOR OPPOSITION
- 31 May 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 May 2023 — ASSIGNED TO EXAMINER
- 17 Aug 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED